Celebrate Cinco de Mayo with Flavorful Deals from 7-Eleven, Inc. and Laredo Taco Company®
Experience big flavor and bigger savings with BOGO burritos and free chips and queso
IRVING, Texas, April 29, 2025 /PRNewswire/ -- 7-Eleven, Inc. is turning up the heat for Cinco de Mayo with sizzling offers that dial up both flavor and fun. On May 5, customers can enjoy festive favorites with exclusive deals from Laredo Taco Company® restaurants and the 7NOW ® Delivery app.
At Laredo Taco Company locations, customers can dig into a buy one, get one offer on any burrito of their choice*, like the Chicken Fajita Burrito or the new Creamy Chipotle Shrimp Burrito. Plus, customers can enjoy free chips and queso**!
In honor of the holiday, the 7NOW Delivery app is bringing the feast straight to customers' doorsteps. Get 50% off Laredo Taco Company orders of $20 or more – perfect for feeding a hungry crew or just a party of one.
'Cinco de Mayo is a time to come together around delicious food and shared traditions,' said William Armstrong, Senior Vice President of Restaurant Operations at 7-Eleven, Inc. 'At Laredo Taco Company locations and across our 7-Eleven family of brands, we're dedicated to bringing customers the bold tastes they love, plus deals that make it easy to join in on the festivities.'
Keep the celebration going at 7-Eleven®, Speedway® and Stripes® stores by raising a toast with friends and family. 7Rewards® and Speedy Rewards® members can enjoy $3 off select large packs of a variety of Mexican beers such as Modelo, Corona and Dos Equis.*** From food to drinks, 7-Eleven has everything to make this Cinco de Mayo memorable.
* Valid on 5/5/25. ©2025 7-Eleven, Inc. All rights reserved.
** Valid from 5/6/25-5/10/25. ©2025 7-Eleven, Inc. All rights reserved.
*** Valid on 5/5/25 on select large packs in participating stores and where legal.©2025 7-Eleven, Inc. All rights reserved.
About 7-Eleven, Inc.
7-Eleven, Inc. is the premier name in the U.S. convenience-retailing industry. Based in Irving, Texas, 7-Eleven operates, franchises and/or licenses more than 13,000 stores in the U.S. and Canada. In addition to 7-Eleven® stores, 7-Eleven, Inc. operates and franchises Speedway®, Stripes®, Laredo Taco Company® and Raise the Roost® Chicken and Biscuits locations. Known for its iconic brands such as Slurpee®, Big Bite® and Big Gulp®, 7-Eleven has expanded into high-quality sandwiches, salads, side dishes, cut fruit and protein boxes, as well as pizza, chicken wings and mini beef tacos. 7-Eleven offers customers industry-leading private brand products at outstanding value. Customers can earn and redeem points on various items in stores nationwide through its 7Rewards® and Speedy Rewards® loyalty programs with more than 80 million members, place an order in the 7NOW® delivery app in over 95% of the convenience retailer's footprint, or rely on 7-Eleven for other convenient services. Find out more online at www.7-eleven.com.
CONTACT: 7-Eleven, Inc.
Corporate Communications
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/celebrate-cinco-de-mayo-with-flavorful-deals-from-7-eleven-inc-and-laredo-taco-company-302437959.html
SOURCE 7-Eleven, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., June 11, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on June 10, 2025, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 115,620 shares of common stock and 57,740 restricted stock units ("RSUs") to 10 new employees under Mirum's 2020 Inducement Plan. The Compensation Committee of Mirum's Board of Directors approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4). Each stock option has an exercise price per share equal to $48.98 per share, Mirum's closing trading price on June 10, 2025, and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The RSUs will vest over three years, with 33% of the underlying shares vesting on each anniversary of the applicable vesting commencement date, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The awards are subject to the terms and conditions of Mirum's 2020 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder. To learn more about Mirum, visit and follow Mirum on Facebook, LinkedIn, Instagram and X. View source version on Contacts Investor Contact: Andrew McKibbenir@ Media Contact: Erin Murphymedia@
Yahoo
34 minutes ago
- Yahoo
Studio 17 Spotlights Kern County SHRM Annual Conference
Presented by: Kern County SHRM On today's Studio 17, Kait Hill spoke with with Jackie Andrade, Conference Director, and Sky Newton, Conference Vice Chair, from Kern County SHRM to discuss their upcoming annual conference. Kern County SHRM plays a key role in connecting the local business community through leadership, professional development, and networking. With a long-standing presence in the region, Kern County SHRM's conference promises powerful keynote speakers and fresh topics that reflect the evolving workplace. The event welcomes not only HR professionals but anyone interested in career growth and leadership skills. Attendees can look forward to dynamic sessions and a vibrant atmosphere that encourages learning and connection. For those wanting to get involved year-round or register for the conference, more information is available on the . Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
34 minutes ago
- Yahoo
City approves task order for Lynn Haven stormwater project
LYNN HAVEN, Fla. (WMBB) – Lynn Haven is making progress on stormwater drainage improvements. It's been a problem for decades, but worsened after Hurricane Michael, causing flooding even during moderate rains. City officials signed a task order today to finish the remainder of the project. In 2022, Lynn Haven received a $1 million legislative appropriation to address long-standing stormwater issues. With clogged pipes and blocked outflows choked by grass and sediment, flooding has been a persistent problem in the community for decades. Dolphin transport underway at Gulf World 'We want to prevent any structural flooding. We want to get water from standing in roadways so emergency vehicles can pass. And of course, you know, our residents to walk down the road if needed in an emergency or be able to leave their home without flooding their cars out,' said Public Works Director Chris Lightfoot. The city divided the project into phases, prioritizing repairs that didn't require permits from the Army Corps of Engineers or the Florida Department of Environmental Protection. That allowed crews to start clearing and maintaining some systems immediately. Some of the work has occurred along 7th Street and Kentucky Avenue, and 13th and Missouri Avenue. Panama City approves new areas for golf cart safety 'The outfall construction that we're doing is basically excavating and armor forming the outfalls to provide a clear flow for the stormwater to get out. Currently, it's grass and sediment that builds up and constantly having to be maintained. It's difficult to maintain because they stay so wet. So we will just get these cleaned out. They will be a permanent structure, and they can flow freely,' Lightfoot added. The city has used about $700,000 so far. The remaining $300,000 will go to trouble spots like East 2nd Street and Illinois off 10th Street. 'That it will allow storm water to recede faster and hopefully not be in our streets and roadways,' Mayor Jesse Nelson said. The entire project is expected to take about 120 days to complete. That work will go out to bid in the near future. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
